Scottish cell signalling unit forging links with industry
This article was originally published in Scrip
Executive Summary
The Scottish Institute for Cell Signalling (SCILLS) at the University of Dundee says its new unit for research into ubiquitylation, the body's mechanism for controlling cell activity, is attracting strong interest from the pharmaceutical industry. The research is expected to lead to the development of new drugs for conditions such as cancer and inflammatory diseases.